Neurizon NUZ-001 Reduces TDP-43 Aggregation in Preclinical ALS Study
Ncardia Launches Ready-to-Use iPSC Assays for CNS Drug Discovery
Ncardia Acquires STAR-CRISPR Technology for Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
The Urgent Need for Reliable Cell Models in ALS Research
Ncardia @ ASGCT 24: The latest updates from Baltimore
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
